Highlights and Clinical Takeaways from Recent Dermatology Studies

Conclusions

• The presentation concludes that several dermatologic therapies and diagnostic tools show promise, but many findings are still early and need larger confirmatory studies before changing routine practice.
• Intermittent dutasteride appears to be a viable alternative to daily finasteride for male androgenetic alopecia, with comparable hair outcomes and more flexible dosing.
• Adding bicalutamide to oral minoxidil for female pattern hair loss does not clearly improve efficacy, but it may reduce bothersome side effects such as dread shed and facial hypertrichosis.
• Biosimilar adalimumab may not be equivalent to originator adalimumab for hidradenitis suppurativa in real-world outcomes, so switching decisions may matter clinically.
• Deucravacitinib looks effective for difficult scalp psoriasis and may be a useful oral option for scalp-predominant disease.
• Psoriasis patients without known cardiovascular disease may still carry a substantial burden of subclinical atherosclerosis, supporting cardiovascular risk assessment and prevention.
• Weight gain appears to be a real but modest class effect of JAK inhibitors and should be discussed with patients when relevant.
• Molluscum contagiosum often resolves over time, but treatment can modestly shorten disease duration, while berdazimer gel offers a more potent treatment option with acceptable tolerability.
• Body dysmorphic disorder in dermatology is strongly shaped by psychosocial factors, and social support appears protective, emphasizing the importance of screening and referral.
• Atopic dermatitis does not appear to delay pubertal development, which is reassuring for families.
• Dermatologic disease burden remains high in low-resource settings such as Nigeria, with infections and infestations especially common, highlighting the need for broader access to care.
• Genital psoriasis is common, significantly affects quality of life, and is often underreported and undertreated unless clinicians ask directly.
• Earbud use may contribute to contact dermatitis presenting as recurrent otitis externa, so patch testing should be considered when standard management fails.
• Many psoriasis and hidradenitis suppurativa patients already meet criteria for GLP-1 receptor agonists based on metabolic factors, suggesting a role for metabolic co-management.
• The neutrophil-to-lymphocyte ratio may be a low-cost prognostic biomarker in melanoma, especially for mortality risk stratification.
• Skin fluorescence imaging may outperform dermoscopy for melanoma detection and could become a useful triage tool for pigmented lesions.
• Patients with skin disease have a measurably higher psychosocial stress burden than controls, supporting routine attention to stress, anxiety, depression, and stigma in dermatology care.